<?xml version="1.0" encoding="utf-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:con="http://www.w3.org/2000/10/swap/pim/contact#" xmlns:cinii="http://ci.nii.ac.jp/ns/1.0/">
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110004863672#article">
<foaf:isPrimaryTopicOf rdf:resource="http://ci.nii.ac.jp/naid/110004863672.rdf" />
<dc:title>Licorice Flavonoid Oil Effects Body Weight Loss by Reduction of Body Fat Mass in Overweight Subjects</dc:title>
<dc:creator>Tominaga Yuji</dc:creator>
<dc:creator>Mae Tatsumasa</dc:creator>
<dc:creator>Kitano Mitsuaki</dc:creator>
<dc:creator>Sakamoto Yoshiro</dc:creator>
<dc:creator>Ikematsu Hideyuki</dc:creator>
<dc:creator>Nakagawa Kaku</dc:creator>
<dc:publisher>公益社団法人日本薬学会</dc:publisher>
<prism:publicationName>Journal of health science</prism:publicationName>
<prism:issn>13449702</prism:issn>
<prism:volume>52</prism:volume>
<prism:number>6</prism:number>
<prism:startingPage>672</prism:startingPage>
<prism:endingPage>683</prism:endingPage>
<prism:publicationDate>2006-12-01</prism:publicationDate>
<dc:description>Licorice flavonoid oil (LFO) is a new dietary ingredient for functional foods consisting of licorice hydrophobic polyphenols in medium-chain triglycerides (MCT). In an effective dose finding study conducted previously, LFO has exhibited a dose-dependent body fat-reducing effect. Here we report the weight-reducing effect of LFO in a placebo-controlled, double-blind, long-term (12 weeks) ingestion study at 300 mg/day, the minimal effective dose observed in the dose finding study. A total of 103 overweight subjects [body mass index (BMI): 24-30] completed this study and were analyzed. Body weight increased in the placebo group, but was maintained at close to preingestion level in the LFO group, resulting in significant (p&lt;0.05) differences in the changes in body weight and BMI between the LFO group and the placebo group at each time-point. Dual-energy X-ray absorptiometry (DXA) measurement of body fat indicated that the weight-reducing effect was attributable to reduced body fat. No clinically significant adverse events occurred during the 12-week ingestion period. To confirm the safety of LFO for practical use we also conducted a placebo-controlled, double-blind safety study in 40 overweight subjects with a 4-week excessive ingestion at 1800 mg/day; 6 times the dose of the 300 mg/day study that exhibited a weight-reducing effect. No clinically significant adverse events occurred during the 4-week ingestion period. Based on these findings in both human studies it was shown that LFO is a safe ingredient for functional foods even for long-term or excessive ingestion, with a potential weight-reducing effect.</dc:description>
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/licorice" dc:title="licorice" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/flavonoid" dc:title="flavonoid" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/body_fat" dc:title="body_fat" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/body_weight" dc:title="body_weight" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/dual-energy_X-ray_absorptiometry" dc:title="dual-energy_X-ray_absorptiometry" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/clinical_trial" dc:title="clinical_trial" />
<dc:date>2006-12-01</dc:date>
<cinii:naid>110004863672</cinii:naid>
<cinii:ncid>AA11316464</cinii:ncid>
<cinii:ndljpi>8548591</cinii:ndljpi>
<dc:language>ENG</dc:language>
<dc:source>CJP</dc:source>
<dc:source>CJPref</dc:source>
<dc:source>NDL</dc:source>
<dc:source>NII-ELS</dc:source>
<dc:source>J-STAGE</dc:source>
<cinii:fulltext>3</cinii:fulltext>
<cinii:references>32</cinii:references>
<cinii:citedBy>2</cinii:citedBy>
<dcterms:isPartOf rdf:resource="http://ci.nii.ac.jp/ncid/AA11316464" dc:title="Journal of health science" />
<rdfs:seeAlso rdf:resource="http://opac.ndl.go.jp/articleid/8548591/jpn" dc:title="NDL-OPAC - 国立国会図書館で本をさがす" />
<rdfs:seeAlso rdf:resource="http://joi.jlc.jst.go.jp/JST.JSTAGE/jhs/52.672?from=CiNii" dc:title="J-STAGE" />
<rdfs:seeAlso rdf:resource="http://search.jamas.or.jp/link/ui/2007159867" dc:title="医中誌 Web" />
<rdfs:seeAlso rdf:resource="http://dx.doi.org/info:doi/10.1248/jhs.52.672" dc:title="CrossRef" />
</rdf:Description>
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110004863672#article" xml:lang="en">
<dc:title>Licorice Flavonoid Oil Effects Body Weight Loss by Reduction of Body Fat Mass in Overweight Subjects</dc:title>
<dc:creator>Tominaga Yuji</dc:creator>
<dc:creator>Mae Tatsumasa</dc:creator>
<dc:creator>Kitano Mitsuaki</dc:creator>
<dc:creator>Sakamoto Yoshiro</dc:creator>
<dc:creator>Ikematsu Hideyuki</dc:creator>
<dc:creator>Nakagawa Kaku</dc:creator>
<dc:publisher>The Pharmaceutical Society of Japan</dc:publisher>
<prism:publicationName>Journal of health science</prism:publicationName>
<dc:description>Licorice flavonoid oil (LFO) is a new dietary ingredient for functional foods consisting of licorice hydrophobic polyphenols in medium-chain triglycerides (MCT). In an effective dose finding study conducted previously, LFO has exhibited a dose-dependent body fat-reducing effect. Here we report the weight-reducing effect of LFO in a placebo-controlled, double-blind, long-term (12 weeks) ingestion study at 300 mg/day, the minimal effective dose observed in the dose finding study. A total of 103 overweight subjects [body mass index (BMI): 24-30] completed this study and were analyzed. Body weight increased in the placebo group, but was maintained at close to preingestion level in the LFO group, resulting in significant (p&lt;0.05) differences in the changes in body weight and BMI between the LFO group and the placebo group at each time-point. Dual-energy X-ray absorptiometry (DXA) measurement of body fat indicated that the weight-reducing effect was attributable to reduced body fat. No clinically significant adverse events occurred during the 12-week ingestion period. To confirm the safety of LFO for practical use we also conducted a placebo-controlled, double-blind safety study in 40 overweight subjects with a 4-week excessive ingestion at 1800 mg/day; 6 times the dose of the 300 mg/day study that exhibited a weight-reducing effect. No clinically significant adverse events occurred during the 4-week ingestion period. Based on these findings in both human studies it was shown that LFO is a safe ingredient for functional foods even for long-term or excessive ingestion, with a potential weight-reducing effect.</dc:description>
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/licorice" dc:title="licorice" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/flavonoid" dc:title="flavonoid" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/body_fat" dc:title="body_fat" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/body_weight" dc:title="body_weight" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/dual-energy_X-ray_absorptiometry" dc:title="dual-energy_X-ray_absorptiometry" />
<foaf:topic rdf:resource="http://ci.nii.ac.jp/keyword/clinical_trial" dc:title="clinical_trial" />
</rdf:Description>
<rdf:Description rdf:about="http://ci.nii.ac.jp/naid/110004863672#article">
<foaf:depiction>
<foaf:Image rdf:about="http://ci.nii.ac.jp/pdfthumbnail/11/1100/110004/110004863672.jpg" />
</foaf:depiction>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000006218435">
<foaf:name xml:lang="en">Tominaga Yuji</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Functional_Food_Ingredients_Division%252C_Kaneka_Corporation">
<foaf:name xml:lang="en">Functional Food Ingredients Division, Kaneka Corporation</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000001644897">
<foaf:name xml:lang="en">Mae Tatsumasa</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Functional_Food_Ingredients_Division%252C_Kaneka_Corporation">
<foaf:name xml:lang="en">Functional Food Ingredients Division, Kaneka Corporation</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000001644889">
<foaf:name xml:lang="en">Kitano Mitsuaki</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Life_Science_Research_Laboratories%252C_Life_Science_RD_Center%252C_Kaneka_Corporation">
<foaf:name xml:lang="en">Life Science Research Laboratories, Life Science RD Center, Kaneka Corporation</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000006218445">
<foaf:name xml:lang="en">Sakamoto Yoshiro</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Kamiitabashi_Clinic">
<foaf:name xml:lang="en">Kamiitabashi Clinic</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/9000006218448">
<foaf:name xml:lang="en">Ikematsu Hideyuki</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Haradoi_Hospital">
<foaf:name xml:lang="en">Haradoi Hospital</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
<foaf:maker>
<foaf:Person rdf:about="http://ci.nii.ac.jp/nrid/1000090309435">
<foaf:name xml:lang="en">Nakagawa Kaku</foaf:name>
<con:organization>
<foaf:Organization rdf:about="http://ci.nii.ac.jp/org/Functional_Food_Ingredients_Division%252C_Kaneka_Corporation">
<foaf:name xml:lang="en">Functional Food Ingredients Division, Kaneka Corporation</foaf:name>
</foaf:Organization>
</con:organization>
</foaf:Person>
</foaf:maker>
</rdf:Description>
</rdf:RDF>

